Type | Subsidiary |
Parent Company | Smith & Nephew |
HQ | Columbia, MD, US |
Founded | 1992 |
Website | osiris.com |
Cybersecurity rating | FMore |
Founding Date | 1992 |
Total Funding | $65 m |
Investors | Mesoblast |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 10.2m | 10.2m | 3.4m | 1.6m | 2.2m | 4.1m | 5.3m | 6.9m | 10.1m | 13.3m | 17.2m | 21.0m | 23.7m | 25.3m | 31.6m | 33.9m | 36.5m |
Cost of goods sold | 55.0k | 139.0k | 387.0k | 552.0k | 732.0k | 1.1m | 1.5m | 1.9m | 2.2m | 2.9m | 3.8m | 4.6m | 5.1m | 5.4m | 8.9m | 9.7m | 9.8m |
Gross profit | 10.2m | 10.1m | 3.1m | 1.1m | 1.4m | 2.9m | 3.8m | 5.0m | 7.8m | 10.4m | 13.4m | 16.4m | 18.5m | 19.9m | 22.8m | 24.2m | 26.7m |
Gross profit Margin, % | 99% | 99% | 89% | 66% | 66% | 72% | 72% | 73% | 78% | 78% | 78% | 78% | 78% | 79% | 72% | 71% | 73% |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 1.5m | 1.4m | 1.6m | 1.1m | 1.1m | 1.3m | 1.6m | 1.8m | 2.3m | 2.7m | 946.0k | 3.7m | 1.6m | 15.8m | 3.4m | 23.1m | 31.7m |
Accounts Receivable | 1.6m | 1.5m | 997.0k | 1.4m | 2.2m | 5.3m | 6.4m | 6.8m | 11.8m | 16.9m | 21.4m | 32.0m | 38.6m | 37.9m | 26.5m | 23.5m | 20.6m |
Prepaid Expenses | 743.0k | 762.0k | 636.0k | 3.4m | 1.1m | 462.0k | 356.0k | 639.0k | 318.0k | 404.0k | 489.0k | 579.0k | 1.2m | 1.2m | 3.1m | 2.9m | 3.4m |
Inventories | 623.0k | 729.0k | 415.0k | 475.0k | 922.0k | 1.6m | 1.7m | 1.7m | 2.3m | 5.5m | 8.8m | 11.9m | 13.3m | 15.8m | 11.0m | 11.1m | 10.6m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 5.8m | 9.8m | (1.3m) | (5.5m) | (8.5m) | (2.7m) | (6.5m) | 1.4m | 2.5m | 622.0k | (2.3m) | 164.0k | 4.4m | ||||
Depreciation and Amortization | 375.0k | 560.0k | 177.0k | 348.0k | 528.0k | 185.0k | 369.0k | 273.0k | 214.0k | 441.0k | 685.0k | 267.0k | 547.0k | 850.0k | 211.0k | 426.0k | 658.0k |
Inventories | (333.0k) | (418.0k) | (394.0k) | (408.0k) | (3.6m) | (6.9m) | (1.0m) | (2.4m) | (4.7m) | 262.0k | (616.0k) | (536.0k) | |||||
Accounts Payable | (1.2m) | 21.0k | 101.0k | 449.0k | 267.0k | (33.0k) |
USD | Q2, 2011 |
---|---|
Financial Leverage | 1.8 x |
When was Osiris Therapeutics founded?
Osiris Therapeutics was founded in 1992.
Who are Osiris Therapeutics key executives?
Osiris Therapeutics's key executives are Samson Tom, Jason Keefer and Alla Danilkovitch.
How many employees does Osiris Therapeutics have?
Osiris Therapeutics has 256 employees.
What is Osiris Therapeutics revenue?
Latest Osiris Therapeutics annual revenue is $142.8 m.
What is Osiris Therapeutics revenue per employee?
Latest Osiris Therapeutics revenue per employee is $557.9 k.
Who are Osiris Therapeutics competitors?
Competitors of Osiris Therapeutics include ACell, Touchlight Genetics and Personal Genome Diagnostics (PGD).
Where is Osiris Therapeutics headquarters?
Osiris Therapeutics headquarters is located at 7015 Albert Einstein Dr, Columbia.
Where are Osiris Therapeutics offices?
Osiris Therapeutics has an office in Columbia.
How many offices does Osiris Therapeutics have?
Osiris Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies